ImmunoHiTech

ImmunoHiTech is a private Israeli biotechnology company focused on immunotherapy and diagnostic products intended to reduce metastatic spread in cancer patients. The company describes its core approach as targeting a protein expressed on the surface of most solid tumors but not on normal cells. Its technology appears aimed at both therapeutic use, including directing anti-tumor immune responses, and diagnostic use, including detection and isolation of rare tumor cells from body fluids. Publicly available information suggests the company remains very early stage, with limited disclosed pipeline detail and no clearly identified clinical-stage assets. ImmunoHiTech is headquartered in Ramat Hasharon, Israel and is led by founder and president Hanoch Slor.